» Articles » PMID: 28977914

Potential Link Between Fusobacterium Enrichment and DNA Methylation Accumulation in the Inflammatory Colonic Mucosa in Ulcerative Colitis

Abstract

Background And Aim: enrichment has been associated with colorectal cancer development. Ulcerative colitis (UC) associated tumorigenesis is characterized as high degree of methylation accumulation through continuous colonic inflammation. The aim of this study was to investigate a potential link between enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in UC.

Methods: In the candidate analysis, inflamed colonic mucosa from 86 UC patients were characterized the methylation status of colorectal a panel of cancer related 24 genes. In the genome-wide analysis, an Infinium HumanMethylation450 BeadChip array was utilized to characterize the methylation status of >450,000 CpG sites for fourteen UC patients. Results were correlated with status.

Results: UC with enrichment (FB-high) was characterized as high degree of type C (for cancer-specific) methylation compared to other (FB-low/neg) samples (<0.01). Genes hypermethylated in FB-high samples included well-known type C genes in colorectal cancer, such as and , and . Multivariate analysis demonstrated that the FB high status held an increased likelihood for methylation high as an independent factor (odds ratio: 16.18, 95% confidence interval: 1.94-135.2, =0.01). Genome-wide methylation analysis demonstrated a unique methylome signature of FB-high cases irrespective of promoter, outside promoter, CpG and non-CpG sites. Group of promoter CpG sites that were exclusively hypermethylated in FB-high cases significantly codified the genes related to the catalytic activity (=0.039).

Conclusion: Our findings suggest that accelerates DNA methylation in specific groups of genes in the inflammatory colonic mucosa in UC.

Citing Articles

Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics.

Martinez-Montoro J, Martin-Nunez G, Gonzalez-Jimenez A, Garrido-Sanchez L, Moreno-Indias I, Tinahones F J Transl Med. 2024; 22(1):1089.

PMID: 39617894 PMC: 11610095. DOI: 10.1186/s12967-024-05746-y.


Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota.

Hridayanka K, Duttaroy A, Basak S Nutrients. 2024; 16(21).

PMID: 39519419 PMC: 11547880. DOI: 10.3390/nu16213587.


Dual Regulation Mechanism of Obesity: DNA Methylation and Intestinal Flora.

Ren Y, Huang P, Zhang L, Tang Y, Luo S, She Z Biomedicines. 2024; 12(8).

PMID: 39200098 PMC: 11351752. DOI: 10.3390/biomedicines12081633.


The Gut and Skin Microbiome and Its Association with Aging Clocks.

Min M, Egli C, Sivamani R Int J Mol Sci. 2024; 25(13).

PMID: 39000578 PMC: 11242811. DOI: 10.3390/ijms25137471.


Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).

Wang Z, Chang Y, Sun H, Li Y, Tang T Oncol Lett. 2024; 27(6):257.

PMID: 38646499 PMC: 11027113. DOI: 10.3892/ol.2024.14390.


References
1.
Signat B, Roques C, Poulet P, Duffaut D . Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011; 13(2):25-36. View

2.
Toyota M, Ahuja N, Herman J, Baylin S, Issa J . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999; 96(15):8681-6. PMC: 17576. DOI: 10.1073/pnas.96.15.8681. View

3.
Issa J, Ahuja N, Toyota M, Bronner M, Brentnall T . Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61(9):3573-7. View

4.
Strauss J, Kaplan G, Beck P, Rioux K, Panaccione R, DeVinney R . Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011; 17(9):1971-8. DOI: 10.1002/ibd.21606. View

5.
Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View